StockData
Zeo ScientifiX, Inc. logo

Zeo ScientifiX, Inc. (ZEOX) stock

ZEOXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Financials through Q2 FY2026, quarter ended Apr 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.91+0.00 (+0.15%)

Close on Oct 19, 2026Market cap $7.08MP/E –Yield –

Zeo ScientifiX total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Zeo ScientifiX's total debt was $247.00K at Apr 30, 2026. For fiscal 2025 it was $243.00K, down 64.3% from the year before. The highest annual figure on record is $680.00K in fiscal 2024.

Annual total debt

PeriodPeriod endValueChange
FY2025Oct 31, 2025$243.00K-64.3%
FY2024Oct 31, 2024$680.00K+3.5%
FY2023Oct 31, 2023$657.00K+2198.2%
FY2022Oct 31, 2022$28.59K-79.6%
FY2021Oct 31, 2021$140.43K+108.6%
FY2020Oct 31, 2020$67.32K-56.1%
FY2019Oct 31, 2019$153.18K–
FY2018Oct 31, 2018$0–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ1 2026Apr 30, 2026$247.00K-64.3%
Q1 FY2026CQ4 2025Jan 31, 2026$245.00K-64.3%
Q4 FY2025CQ3 2025Oct 31, 2025$243.00K-64.3%
Q3 FY2025CQ2 2025Jul 31, 2025$698.00K+4.3%
Q2 FY2025CQ1 2025Apr 30, 2025$692.00K+4.4%
Q1 FY2025CQ4 2024Jan 31, 2025$686.00K+4.4%
Q4 FY2024CQ3 2024Oct 31, 2024$680.00K+45.3%
Q2 FY2024CQ1 2024Apr 30, 2024$669.00K+113.1%
Q1 FY2024CQ4 2023Jan 31, 2024$663.00K+2219.2%
Q4 FY2023CQ3 2023Oct 31, 2023$657.00K+505.7%
Q3 FY2023CQ2 2023Jul 31, 2023$468.05K+233.3%
Q2 FY2023CQ1 2023Apr 30, 2023$314.00K+366.4%
Q4 FY2022CQ3 2022Oct 31, 2022$28.59K-81.3%
Q1 FY2022CQ4 2021Jan 31, 2022$108.46K-34.6%
Q4 FY2021CQ3 2021Oct 31, 2021$140.43K-20.8%
Q4 FY2020CQ3 2020Oct 31, 2020$67.32K–
Q4 FY2019CQ3 2019Oct 31, 2019$153.18K–
Q3 FY2019CQ2 2019Jul 31, 2019$165.78K–
Q2 FY2019CQ1 2019Apr 30, 2019$177.40K–
Q4 FY2018CQ3 2018Oct 31, 2018$0–

More Zeo ScientifiX figures

See a number that looks wrong?